Disentangling Rhythmic and Aperiodic Neural Activity: Investigating the Role of GABA Modulation in Sensorimotor Beta Oscillations

Beta oscillations (13–30 Hz) in the sensorimotor cortex are fundamental to motor control and are disrupted in motor disorders such as Parkinson’s disease and stroke. Animal studies and pharmacological research in humans have implicated GABAergic mechanisms in modulating these oscillations. Here, we explored the impact of GABAergic modulation on sensorimotor beta oscillations using magnetoencephalography (MEG) during a finger abduction task, with participants administered gaboxadol and zolpidem, two GABA-A positive allosteric modulators. We combined traditional oscillatory analyses with spectral parametrisation methods to separate periodic and aperiodic neural components. Time-frequency representations (TFRs) showed that gaboxadol induced a stronger modulation of beta dynamics than zolpidem, leading to deeper beta desynchronisation during movement and a more pronounced post-movement beta rebound. When accounting for aperiodic activity, gaboxadol showed modest effects limited to movement initiation, with increased beta power during movement onset but no significant impact during post-movement rebound. In contrast, zolpidem significantly enhanced beta power and altered aperiodic components, suggesting differential influences on GABAergic modulation and excitation-inhibition balance. These results underscore the necessity of distinguishing between periodic and aperiodic signals in spectral measures to improve the interpretation of neural oscillatory data.